PHARMACOKINETICS AND DOSE PROPORTIONALITY OF LORATADINE

被引：106

作者：

HILBERT, J

RADWANSKI, E

WEGLEIN, R

LUC, V

PERENTESIS, G

SYMCHOWICZ, S

ZAMPAGLIONE, N

机构：

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 27卷 / 09期

关键词：

D O I：

10.1002/j.1552-4604.1987.tb03090.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：694 / 698

页数：5

共 14 条

[1] PHARMACOKINETICS OF DESMETHYLIMIPRAMINE AND NORTRIPTYLINE IN MAN AFTER SINGLE AND MULTIPLE ORAL DOSES - CROSSOVER STUDY [J].

ALEXANDERSON, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 5 (01) :1-+

[2] PHARMACOKINETICS OF NORTRIPTYLINE IN MAN AFTER SINGLE AND MULTIPLE ORAL DOSES - PREDICTABILITY OF STEADY-STATE PLASMA CONCENTRATIONS FROM SINGLE-DOSE PLASMA-LEVEL DATA [J].

ALEXANDERSON, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 4 (02) :82-+

[3]

AMSTERDAM J, 1980, AM J PSYCHIAT, V137, P653

[4] EVALUATION OF THE CNS PROPERTIES OF SCH-29851, A POTENTIAL NON-SEDATING ANTIHISTAMINE [J].

BARNETT, A ;

IORIO, LC ;

KREUTNER, W ;

TOZZI, S ;

AHN, HS ;

GULBENKIAN, A .

AGENTS AND ACTIONS, 1984, 14 (5-6) :590-597

[5] PHARMACOLOGICAL EVALUATION OF LORATADINE (SCH 29851), CHLORPHENIRAMINE AND PLACEBO [J].

BATENHORST, RL ;

BATENHORST, AS ;

GRAVES, DA ;

FOSTER, TS ;

KUNG, M ;

GURAL, RP ;

AMKRAUT, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :247-250

[6]

GUTKOWSKI A, 1986, 13TH C EUR AC ALL CL

[7]

KAMINSZCZIK I, 1986, 13TH C EUR AC ALL CL

[8]

KATCHEN B, 1985, ANN ALLERGY, V55, P366

[9]

METZLER CM, 1974, BIOMETRICS, V30, P562

[10] CLINICAL PHARMACOKINETICS OF H-1-RECEPTOR ANTAGONISTS (THE ANTIHISTAMINES) [J].

PATON, DM ;

WEBSTER, DR .

CLINICAL PHARMACOKINETICS, 1985, 10 (06) :477-497

← 1 2 →